Diagnostics
Tirzepatide-Associated Severe Hepatocellular Injury: A Case Report and Diagnostic Considerations
The paper
Soonchunhyang University Hospital Bucheon
Diagnostics, 27 Jul 2026
Related
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
